Sanofi eyes COVID-19 vaccine approval to drive earnings

This content originally appeared on Reuters and was authored by Reuters

Print Share Comment Cite Upload Translate Updates

APA

Reuters | Sciencx (2022-02-04T11:24:46+00:00) Sanofi eyes COVID-19 vaccine approval to drive earnings. Retrieved from https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/

MLA

" » Sanofi eyes COVID-19 vaccine approval to drive earnings." Reuters | Sciencx - Friday February 4, 2022, https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/

HARVARD

Reuters | Sciencx Friday February 4, 2022 » Sanofi eyes COVID-19 vaccine approval to drive earnings., viewed ,<https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/>

VANCOUVER

Reuters | Sciencx - » Sanofi eyes COVID-19 vaccine approval to drive earnings. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/

CHICAGO

" » Sanofi eyes COVID-19 vaccine approval to drive earnings." Reuters | Sciencx - Accessed . https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/

IEEE

" » Sanofi eyes COVID-19 vaccine approval to drive earnings." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/. [Accessed: ]

rf:citation

» Sanofi eyes COVID-19 vaccine approval to drive earnings | Reuters | Sciencx | https://www.scien.cx/2022/02/04/sanofi-eyes-covid-19-vaccine-approval-to-drive-earnings/ |

Please log in to upload a file.

There are no updates yet.
Click the Upload button above to add an update.

You must be logged in to translate posts. Please log in or register.

Related Posts